Insider Trading History of M. Arkin (1999) Ltd.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by M. Arkin (1999) Ltd. since 2010. The trader's CIK number is 1467669. At the time of the last reporting, M. Arkin (1999) Ltd. was the Other of Neurogesx Inc. (stock ticker symbol NGSX). Also see all insider trading activities at Neurogesx Inc.

Note that in the past M. ARKIN (1999) LTD. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by M. Arkin (1999) Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 OREX 0 $0 260,000 $1,234,770 0 $0

Yearly summary of insider trading at Ophthalmic Imaging Systems (OISI) by M. Arkin (1999) Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 OISI 124,286 $87,000 0 $0 0 $0

Yearly summary of insider trading at Neurogesx Inc (NGSX) by M. Arkin (1999) Ltd.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 NGSX 0 $0 686,746 $2,087,815 0 $0
2009 NGSX 1,606,860 $12,595,440 0 $0 0 $0


Insider trading activities at 3 companies by M. Arkin (1999) Ltd.:

1. Orexigen Therapeutics, Inc. (OREX)

2. Ophthalmic Imaging Systems (OISI)

3. Neurogesx Inc (NGSX)

Table 1. Insider trading of Orexigen Therapeutics, Inc. (OREX) by M. Arkin (1999) Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-07-12 OREX Sale 155,000 4.15 643,095
2010-07-15 OREX Sale 105,000 5.63 591,675

Table 2. Insider trading of Ophthalmic Imaging Systems (OISI) by M. Arkin (1999) Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-01-06 OISI Buy 124,286 .70 87,000

Table 3. Insider trading of Neurogesx Inc (NGSX) by M. Arkin (1999) Ltd.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-08-09 NGSX Sale 81,359 2.15 175,165
2011-08-10 NGSX Sale 82,109 2.00 164,546
2011-06-27 NGSX Sale 1,079 2.10 2,270
2011-06-24 NGSX Sale 7,499 2.10 15,755
2011-06-23 NGSX Sale 50,000 2.09 104,550
2011-06-16 NGSX Sale 300,000 3.21 961,500
2011-03-24 NGSX Sale 32,600 4.07 132,616
2011-03-25 NGSX Sale 120,000 4.02 482,880
2011-03-23 NGSX Sale 12,100 4.01 48,533
2009-12-31 NGSX Buy 2,400 7.81 18,734
2010-01-20 NGSX Buy 1,300 7.10 9,228
2009-11-19 NGSX Buy 53,000 8.29 439,635
2010-01-21 NGSX Buy 8,768 7.09 62,147
2009-12-11 NGSX Buy 5,600 7.79 43,646
2009-12-02 NGSX Buy 7,600 8.31 63,140
2009-12-30 NGSX Buy 2,500 7.60 19,010
2009-11-18 NGSX Buy 36,323 8.51 309,108
2010-01-07 NGSX Buy 2,500 7.09 17,730
2010-01-04 NGSX Buy 5,000 7.66 38,320
2009-12-14 NGSX Buy 3,600 7.82 28,137
2009-12-10 NGSX Buy 8,000 7.76 62,072
2010-01-25 NGSX Buy 2,199 7.18 15,797
2010-01-22 NGSX Buy 7,200 7.18 51,696
2009-12-03 NGSX Buy 7,000 8.31 58,198
2009-12-04 NGSX Buy 35,000 7.89 276,290
2010-02-04 NGSX Buy 9,547 7.23 69,015
2010-02-05 NGSX Buy 704 7.24 5,094
2010-02-08 NGSX Buy 21,000 7.21 151,347
2010-02-10 NGSX Buy 77,400 7.27 562,543
2010-02-09 NGSX Buy 19,795 7.25 143,513
2010-01-26 NGSX Buy 4,422 7.15 31,599
2010-01-27 NGSX Buy 6,284 7.09 44,578
2010-01-29 NGSX Buy 5,521 7.06 38,994
2010-02-02 NGSX Buy 2,000 7.25 14,490
2010-02-03 NGSX Buy 13,152 7.21 94,865
2010-01-19 NGSX Buy 209 7.10 1,483
2009-11-23 NGSX Buy 13,600 8.71 118,496
2009-11-30 NGSX Buy 20,000 8.07 161,460
2009-12-07 NGSX Buy 8,000 7.53 60,224
2009-12-08 NGSX Buy 7,600 7.55 57,364
2009-12-09 NGSX Buy 10,000 7.45 74,450
2009-09-11 NGSX Buy 382,000 7.70 2,941,400
2009-09-15 NGSX Buy 786,000 7.97 6,266,778
2010-01-14 NGSX Buy 3,736 7.09 26,473
2010-01-15 NGSX Buy 9,800 7.08 69,344
2009-11-20 NGSX Buy 15,000 8.41 126,195
2009-12-29 NGSX Buy 3,100 7.37 22,847

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by M. Arkin (1999) Ltd. (Other of Neurogesx Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.